NVS acquires MOR.DE/(Nasdaq:MOR) for €68/sh—a 61% premium to yesterday’s close in Frankfurt, Germany: https://www.novartis.com/news/media-releases/novartis-strengthen-oncology-pipeline-agreement-acquire-morphosys-ag-eur-68-share-or-aggregate-eur-27bn-cash The nominal deal value is €2.7B ($2.9B).